The Effect of Adipose Tissue Mesenchymal Stem Cells and Melatonin in a Rat Model of Renal Ischemia Reperfusion Injury.
Yaşar FK., Çil N., Önder E., Avcı E., Özlülerden Y., Abban Mete G.
Animal Study on Acute Kidney Injury, published in Int J Urol (2025) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Animal Study
- Journal
- Int J Urol (2025)
- Country
- Australia
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 40213879
- DOI
- 10.1111/iju.70054
- Citations
- 1
Abstract (original English)
We aimed to determine the effects of adipose-derived mesenchymal stem cells (AD-MSCs) and melatonin on the kidney in rats with ischemia-reperfusion injury. Sixty male rats were divided into six groups: Control group (C) (n: 10), Sham group (S) (n: 10), Ischemia Reperfusion group (IR) (n: 10), Group that was treated with melatonin intraperitoneally after ischemia reperfusion (IR+M) (n: 10), Group in which AD-MSCs were applied locally after ischemia reperfusion (IR+MSC) (n: 10), and group that after IR, melatonin and AD-MSCs were administered (IR+MSC+M) (n: 10). Five rats from each group were sacrificed on day 3 and five of them on day 14. Blood samples were analyzed for BUN and creatinine. Histological analysis was performed. BUN and creatinine levels were higher in the IR group compared to the groups (p < 0.05). There was a statistically significant decrease in creatinine levels in the IR+MSC+M group on day 14. BUN levels decreased significantly in the M and IR+MSC+M groups (p < 0.05). Losses in the glomerular epithelium and tubule cells, enlargement, and hemorrhage areas in the bowman space were detected in the IR group. The histologic scoring was significantly lower in the IR+MSC+M group on the 14th day (p < 0.05). While Caspase-3 and Bax expression increased in the IR group, it decreased in the treatment group, especially on day 14 (p < 0.05). Bcl-2 expression was negative i
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
Worldwide hotspots and trends in stem cell therapy for kidney disease in the last decade: a bibliometric and visualization analysis from 2015 to 2024
Systematic Review on Chronic Kidney Disease, Acute Kidney Injury, published in Front Immunol (2025) — summary generated from the PubMed abstract.
- 2025
Front Immunol2 citations - Level AMeta-analysisEurope PMC
Protective role of exosomes in renal ischemia-reperfusion injury: a systematic review and meta-analysis
Meta-analysis on Chronic Kidney Disease, Acute Kidney Injury, published in Front Pharmacol (2025) — summary generated from the PubMed abstract.
- 2025
Front Pharmacol1 citations - Level AMeta-analysisEurope PMC
Extracellular vesicles for ischemia/reperfusion injury-induced acute kidney injury: a systematic review and meta-analysis of data from animal models
Meta-analysis on Acute Kidney Injury, published in Syst Rev (2022) — summary generated from the PubMed abstract.
- 2022
Syst Rev8 citations - Level AMeta-analysisEurope PMC
Extracellular vesicles for acute kidney injury in preclinical rodent models: a meta-analysis
Meta-analysis with a reported sample of 552 on Acute Kidney Injury, Chronic Inflammation, published in Stem Cell Res Ther (2020) — summary generated from the PubMed abstract.
- 2020
- n = 552
Stem Cell Res Ther35 citations - Level AMeta-analysisPubMed
Concise Review: Using Fat to Fight Disease: A Systematic Review of Nonhomologous Adipose-Derived Stromal/Stem Cell Therapies.
Meta-analysis on Osteoarthritis, Acute Kidney Injury, Cardiovascular Disease, Stroke Research, published in Stem Cells (2018) — summary generated from the PubMed abstract.
- 2018
Stem Cells101 citations - Level AMeta-analysisEurope PMC
Extracellular vesicles derived from mesenchymal stromal cells may possess increased therapeutic potential for acute kidney injury compared with conditioned medium in rodent models: A meta-analysis
Meta-analysis on Chronic Kidney Disease, Acute Kidney Injury, published in Exp Ther Med (2016) — summary generated from the PubMed abstract.
- 2016
Exp Ther Med17 citations